A nurse is educating a client with MS about baclofen therapy. Which statement indicates a need for further teaching?

Rationale: A. Baclofen is a centrally acting skeletal muscle relaxant that targets the GABA-B receptors in the spinal cord, inhibiting excitatory neurotransmission. By reducing the frequency and severity of muscle spasms, stiffness, and hypertonicity, it helps improve mobility, ADLs, and overall comfort in patients with MS. This demonstrates correct understanding of the therapeutic purpose of the medication. B. Both baclofen and alcohol are CNS depressants, which can lead to additive effects such as excessive drowsiness, dizziness, hypotension, or impaired coordination, increasing the risk of falls or accidents. Avoiding alcohol ensures patient safety, especially during initiation or dose adjustments. C. Stopping baclofen abruptly is dangerous. Sudden discontinuation can cause rebound spasticity, severe muscle rigidity, hallucinations, seizures, fever, and even life-threatening complications. Safe discontinuation requires a gradual tapering schedule under medical supervision. This statement indicates the patient does not understand the importance of safe medication management and the physiologic consequences of sudden withdrawal. D. Drowsiness, fatigue, and generalized weakness are common CNS-related adverse effects of baclofen, particularly at the start of therapy or after dose increases. Educating patients about these effects helps them anticipate changes, avoid risky activities (e.g., driving or operating machinery), and adhere to the regimen while monitoring tolerance.